A global leader in scientific instruments and analytical solutions, the company specializes in molecular and materials research, as well as industrial and applied analysis. Its products are widely used in life sciences, pharmaceuticals, and advanced materials, making it a key player for investors focused on innovation-driven industries.
1 member of Congress has disclosed 1 trade in Bruker Corporation (BRK), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-02-13 | MARKWAYNE MULLIN | sell | $15K – $50K |